A Prospective, Open -Label Active -Controlled study to Evaluate the Pharmacokinetics Pharmacodynamics, Saftey and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of Age after the Fontan procedure
Research Grant
Administered By
Pediatrics, Cardiology
Awarded By
Janssen Research & Development, LLC
Start Date
June 1, 2016
End Date
July 6, 2021
Administered By
Pediatrics, Cardiology
Awarded By
Janssen Research & Development, LLC
Start Date
June 1, 2016
End Date
July 6, 2021